SAB Biotherapeutics, Inc.
SABS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,898 | $56,566 | $15,047 | $33,207 |
| Short-Term Investments | $11,863 | $0 | $0 | $0 |
| Receivables | $55 | $0 | $5,557 | $8,011 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,977 | $2,341 | $1,494 | $8,975 |
| Total Curr. Assets | $23,792 | $58,907 | $22,097 | $50,192 |
| Property Plant & Equip (Net) | $19,921 | $24,684 | $28,340 | $30,949 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $482 | $350 | $468 | $0 |
| Total NC Assets | $20,403 | $25,034 | $28,807 | $30,949 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $44,195 | $83,941 | $50,905 | $81,141 |
| Liabilities | – | – | – | – |
| Payables | $1,695 | $946 | $3,679 | $4,459 |
| Short-Term Debt | $812 | $1,853 | $1,396 | $3,100 |
| Tax Payable | $0 | $40 | $50 | $216 |
| Deferred Revenue | $0 | $1,322 | $0 | $100 |
| Other Curr. Liab. | $5,473 | $6,652 | $9,868 | $18,580 |
| Total Curr. Liab. | $7,980 | $10,813 | $14,993 | $26,455 |
| LT Debt | $3,857 | $4,054 | $4,533 | $5,416 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6,389 | $11,774 | $321 | $10,720 |
| Total NC Liab. | $10,246 | $15,828 | $4,853 | $16,136 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3,857 | $4,856 | $4,614 | $6,719 |
| Total Liabilities | $18,226 | $26,642 | $19,847 | $42,591 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $5 | $4 |
| Retained Earnings | -$124,169 | -$90,064 | -$47,870 | -$29,129 |
| AOCI | -$135 | $26 | $0 | $0 |
| Other Equity | $150,273 | $147,336 | $78,923 | $67,675 |
| Total Equity | $25,970 | $57,299 | $31,058 | $38,550 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $44,195 | $83,941 | $50,905 | $81,141 |
| Net Debt | -$4,229 | -$50,659 | -$9,118 | -$24,691 |